Previous 10 | Next 10 |
Bionano Genomics press release ( NASDAQ: BNGO ): Q2 Net loss of $32.16M. Revenue of $6.67M (+72.8% Y/Y) beats by $0.39M . Gross margin for Q2 2022 was 22%, compared to 37% from Q2 2021 At June 30, 2022, the Company had cash, cash equivalents, and available...
- 73% year-over-year revenue growth in Q2 2022 - Achieved all 1H 2022 ELEVATE! milestones - Strong balance sheet with $187.3 million in cash, cash equivalents, and available-for-sale securities at the end of Q2 2022 - Conference call today, August 4th, 2022 at 4:...
Applied DNA Sciences ( APDN ) +116% . Poseida Therapeutics ( PSTX ) +81% . Ping Identity Holding ( PING ) +60% Non-GAAP EPS of -$0.34 misses by $0.22, revenue of $72.03M misses by $1.27M. Alnylam Pharmaceuticals ( ALNY ) +47% as Phase 3 tr...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotechnology firm Bionano Genomic (NASDAQ: BNGO ), which specializes in the development of a nanoscale imaging and analytics platform, generated significant headlines when it announced the results of its landmark re...
SAN DIEGO, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of the first study to evaluate the utility of optical genome mapping (OGM) for myelodysplastic syndrome (MDS) prognostication. In the peer-reviewed study, published in Leukem...
SAN DIEGO, July 28, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced that it will host a conference call and live webcast on Thursday, August 4th, 2022 at 4:30 p.m. Eastern Time to report financial results for the second quarter 2022 and to highlight recent corpor...
Dr. Alka Chaubey, chief medical officer at Bionano, will host a sponsored vendor panel presentation on the integration of optical genome mapping (OGM) and next generation sequencing (NGS) for clinical research in leukemia and lymphoma Four scientific platform presentati...
SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced publication of a study using optical genome mapping (OGM) to investigate numerical and structural changes to two induced pluripotent stem cell (iPSC) lines, WTC-11 and Tuba1-GFP, during long-...
What Are Penny Stocks? Penny stocks are shares of companies trading for less than $5 per share. Some traders will have definitions of penny stocks , including stocks trading for $0.99 or less. No matter how they’re defined, it comes secondary to the reason for wondering what ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips As many commentators have pointed out recently, the stock market is pricing in a recession that’s not going to arrive anytime soon. As a result, there are now many good stocks to buy on weakness. The best stocks to b...
News, Short Squeeze, Breakout and More Instantly...
Bionano Genomics Inc. Company Name:
BNGO Stock Symbol:
NASDAQ Market:
Bionano Genomics Inc. Website:
A record 31 scientific presentations and posters at the 2024 European Society for Human Genetics (ESHG) Annual Conference and 8 scientific presentations and posters at the 2024 American Cytogenomics Conference ( ACC) will highlight the application of optical genome mapping...
SAN DIEGO, May 28, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics Inc. (“Bionano” or the “Company”) (NASDAQ: BNGO) today announced that it has completed a private placement of senior secured convertible debentures due May 24, 2026. The Company received gross proceeds of $18...